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BACKGROUND: Aortic stenosis–related mortality might vary across demographic subsets, regions, and states in the United 
States.
METHODS AND RESULTS: We reviewed the death certificate data from the Centers for Disease Control and Prevention Wide-Ranging 
OnLine Data for Epidemiologic Research database to examine aortic stenosis–related mortality trends from 2008 to 2018. Crude 
and age-adjusted mortality rates (AAMRs) per 100 000 people and annual percentage change with 95% CIs were calculated. 
Between 2008 and 2018, AAMR reduced from 12.7 to 11.5 (average annual percentage change, −1.0 [95% CI, −1.5 to −0.5]), 
because of an accelerated decline between 2015 and 2018 (annual percentage change, −4.4 [95% CI, −6.0 to −2.7]). Older (aged 
>85 years), male, and White patients had higher death rates than younger, female, and non-White patients, respectively. Although 
mortality reduction was similar across sexes, significant mortality reduction was limited to White patients only. The AAMRs were 
higher in rural than urban areas. States with AAMRs >90th percentile were distributed in the West and the Northeast, and <10th 
percentile in the South. The AAMRs for sex and race were highest in the West and lowest in the South. None of the states located 
in the Midwest showed a significant reduction in mortality. Mortality remained stable for hospital setting and nursing home/long-
term care facility, except that the number of deaths increased at home and hospice facility since 2014.
CONCLUSIONS: The reduction in mortality in patients with aortic stenosis was not consistent among demographic subsets and 
states. The substantial public health and economic implications call for determination of underlying clinical and socioeconomic 
factors to narrow the gap.
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Aortic stenosis (AS) is one of the most common valvular problems associated with significant morbidity and mortality in the United States.1,2 
Before transcatheter aortic valve replacement (TAVR) 
therapy, surgical aortic valve replacement (AVR) was 
considered the gold standard to improve the progno-
sis.3 Consequently, a significant proportion of elderly 
patients with significant multimorbidity burden were left 
untreated. There has been a significant improvement in 
life expectancy in older patients after TAVR.1 However, 
the survival benefit does not appear to be similar in 
non-White compared with White patients.1,4 Moreover, 
geographical variations in the use of TAVR have 
demonstrated contrasting patterns of in-hospital mor-
tality in the US regions.5
Prior data through 2017 suggested that AS-related 
mortality did not improve in nonmetropolitan popu-
lations.1 In view of striking regional socioeconomic 
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disparities and variations in TAVR volumes,5,6 it is im-
perative to identify the patterns of AS-related mortality 
at the state level in the United States. Moreover, be-
cause prior data primarily focused on mortality trends 
in the inpatient setting,4,5 assessment of contempo-
rary trends for individuals with AS is warranted. Death 
certificates remain the key data source for measuring 
longitudinal global and local death trends in public 
health.6 Accordingly, we used a national-level data-
base examining death certificates to measure AS-
related mortality trends in the United States, stratified 
by demographic and regional characteristics.
METHODS
The Centers for Disease Control and Prevention Wide-
Ranging OnLine Data for Epidemiologic Research data 
sets used in this project are publicly available and are 
easily replicable from the methods described in the 
article.
Data Source
We analyzed the Mortality Multiple Cause-of-Death 
Public Use Record from the National Center for Health 
Statistics database, which provides mortality data for 
all US deaths, merged with death certificate data from 
the Centers for Disease Control and Prevention Wide-
Ranging OnLine Data for Epidemiologic Research da-
tabase.7 This database includes the assigned cause 
of mortality from all death certificates filed in the 50 
states and District of Columbia.8 We selected natural 
deaths (defined by the World Health Organization as 
the disease or injury that initiated the events leading 
directly to death as entered by the physician on the 
death certificate) attributed to AS.7,9 In multiple co-
morbidities (common in AS), the underlying cause is 
determined by the condition sequence on the certifi-
cate, provision of the International Classification of the 
Diseases, Tenth Revision (ICD-10) codes, and associ-
ated selection rules and modifications.7,9 We identified 
AS-related cases using ICD-10 revision codes: I06.0, 
I06.2, I35.0, and I35.20.1 To counter the potential as-
certainment bias, AS-related mortality rates were cor-
roborated with all-cause, cardiovascular (I00-I78), and 
cancer-related (C00-C97) mortality (Figure S1); sex- 
and race-stratified analyses were performed for can-
cer mortality (Figures S2 and S3) to validate estimates 
of AS-related mortality. This study did not require insti-
tutional review board approval because we analyzed 
government-issued public-use data without individual 
identifiable information.
Data Extraction
The number of AS-related deaths and population size 
were abstracted from 2008 to 2018. This period was 
selected (1) to document contemporary 10-year trends 
in AS-related mortality and (2) to approximate the 
changing AS mortality patterns most closely in relation 
to use of TAVR in the United States. The data were ab-
stracted on age, sex, race, region, states, and place of 
death. For age, we selected patients aged ≥45 years1, 
and stratified them into 10-year age groups. Race was 
identified as White, Black, Hispanic, American Indian/
Alaskan Native (North, Central, and South American 
Indians, Eskimos, and Aleuts), and Asian/Pacific 
Islander (Chinese, Filipino, Hawaiian, Japanese, and 
other Asian or Pacific Islanders). Regions were clas-
sified according to Census Bureau–defined regions 
into Northeast, Midwest, South, and West.7 Using 
the National Center for Health Statistics Urban-Rural 
Classification Scheme, we divided our population into 
urban (large metropolitan area [≥1 million], medium/
small metropolitan area [50 000–999 999]) and rural 
(<50 000) counties per the 2013 US census classifica-
tion.10 Place of death was categorized as medical facil-
ity (inpatient, outpatient, or emergency room), home, 
CLINICAL PERSPECTIVE
What Is New?
• Between 2008 and 2018, aortic stenosis–related 
mortality reduced in the United States, because of 
an accelerated decline between 2015 and 2018.
• Demographic differences existed, whereas 
geographical patterns demonstrated higher 
burden of mortality in the rural areas or states 
located in the West and the Northeast.
What Are the Clinical Implications?
• The demographic and regional variations in aortic 
stenosis mortality might have stemmed from clini-
cal and behavioral heterogeneities as well as so-
cioeconomic disparities, and limited health care 
access among patients.
• The substantial public health implications call 
for identification of underlying clinical and social 
determinants of health to narrow the differences 
in aortic stenosis mortality.
Nonstandard Abbreviations and Acronyms
AS aortic stenosis
APC annual percentage change
AAPC average annual percentage change
AAMR age-adjusted mortality rate
AVR aortic valve replacement
TAVR transcatheter aortic valve replacement
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hospice facility, nursing home/long-term care, and 
other.
Statistical Analysis
The crude death rates for individual years were calcu-
lated by dividing the number of AS-related deaths by 
the total corresponding population. The annual mortal-
ity rates were calculated per 100 000 population with 
the corresponding 95% CIs.11 The mortality rates were 
age-adjusted based on the US standard population 
from the year 2000. Temporal trends in mortality were 
examined to identify changes in slope using Joinpoint 
Regression Program version 4.7.0.0, which models 
consecutive linear segments on a log scale, con-
nected by joinpoints, where the segments converge.12 
Annual percentage change (APC) with 95% CIs were 
calculated for the line segments linking a joinpoint 
using Monte Carlo permutation test. We estimated the 
weighted average of the APCs to calculate the aver-
age APC (AAPC) for entire study period (2008–2018). 
The AAPC is a summary estimate of the trend over a 
prespecified fixed time interval, which allows provision 
of a single numerical measure to describe the AAPCs 
over a duration of multiple years.13 This measure is valid 
even if the joinpoint model suggests changes in trends 
during those years. Slopes were considered increas-
ing or decreasing if the estimated slope differed sig-
nificantly from zero.12 The statistical significance was 
determined by 2-sided t testing (P=0.05).
RESULTS
Between 2008 and 2018, 176 743 AS-related deaths 
occurred, corresponding to age-adjusted mortality 
rate (AAMR) of 12.7 (95% CI, 12.6–12.8). The APC in 
AAMR was stable between 2008 and 2015 (0.4 [95% 
CI, −0.02 to 0.91]), but there was an accelerated de-
cline between 2015 and 2018 (−4.4 [95% CI, −6.0 to 
−2.7]; Figure 1). Overall, AAMR reduced from 12.7 (95% 
CI, 12.5–12.9) to 11.5 (95% CI, 11.3–11.6) with AAPC of 
−1.0 (95% CI, −1.5 to −0.5).
Demographic Patterns
The crude mortality rates increased with age, with 
exponential distribution (Figure 2). AS-related mortal-
ity reduction was most pronounced in patients who 
were aged 75 to 84 years (AAPC, −2.2 [95% CI, −2.9 
to −1.6]). The mortality trend remained flat in patients 
aged >85  years, because of significant increase in 
APC in crude death rate between 2008 and 2015 (0.8 
[95% CI, 0.2–1.5]), followed by a significant downtrend 
between 2015 and 2018 (−4.1 [95% CI, −6.5 to −1.7]; 
Figure S4). Tables S1 and S2 report crude and AAMRs 
for AS-related mortality; and Table S3 reports the ab-
solute number of AS-related deaths grouped by sex 
and race in the United States. Overall, men had higher 
AAMRs than women, and White patients had higher 
AAMRs than other races.
A consistent reduction in mortality was noted in 
women (AAPC, −1.0 [95% CI, −1.5 to −0.4]) and men 
(AAPC, −1.0 [95% CI, −1.4 to −0.46]), because of ac-
celerated mortality decline since 2015 in women and 
2014 in men into subsequent years (Figure 1). However, 
this downtrend was not consistent across race. In 
White patients, APC in AAMR initially increased be-
tween 2008 and 2015 (0.6 [95% CI, 0.2–1.0]), followed 
by reduction through 2018 (−4.0 [95% CI, −5.4 to 
−2.6]), translating into AAPC of −0.8 (95% CI, −1.2 to 
Figure 1. Overall and sex-stratified aortic stenosis–related mortality rates in the United States, 2008 to 2018.
*Indicates that the annual percentage change (APC) is significantly different from zero at α=0.05.
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−0.4). Conversely, in Black, American Indian/Alaskan 
Native, and Hispanic patients, the mortality trends re-
mained static, except in Asian/Pacific Islanders, where 
mortality declined between 2013 and 2018 (−4.2 [95% 
CI, −7.5 to −0.8]; Figure 3).
Geographical Patterns
Between 2008 and 2018, the AAMRs were higher in 
rural (13.3–14.3) than urban (12.9–11.5) areas (Figure 
S5). In the urban areas, the APC in AAMR was stable 
between 2008 and 2014 (0.6 [95% CI, −0.1 to 1.4]), 
but there was an accelerated decline between 2014 
and 2018 (−3.3 [95% CI, −4.6 to −2.0]). Conversely, in 
the rural area, APC in AAMR increased between 2008 
and 2015 (2.4 [95% CI, 1.7–3.1]), followed by a decline 
between 2015 and 2018 (−3.4 [95% CI, −5.8 to −0.9]).
Across the states, AAMRs varied from 8.0 (95% CI, 
7.6–8.4) to 26.6 (95% CI, 25.9–27.3; Figure 4). States 
with AAMRs >90th percentile were distributed in the 
West and the Northeast regions (Oregon, Vermont, 
Washington, Maine, New Hampshire, and Idaho). 
States with AAMRs <10th percentile were clustered 
in the South (Texas, Mississippi, District of Columbia, 
Georgia, and Alabama) (Table S4). The AAMRs for sex 
and race were highest in the West and lowest in the 
South. Sex- and age-specific differences were most 
prominent in the West and least prominent in the 
Northeast (Figure  5). Race- and age-specific differ-
ences were most prominent in the Northeast and least 
prominent in the South. Death rates classified by sex 
and race for each individual state are shown in Tables 
S1 and S2.
Figure 2. Aortic stenosis–related mortality rates in the US regions by age and sex, 2008 to 2018.
Figure 3. Aortic stenosis–related mortality rates stratified by race in the United States, 2008 to 2018.
*Indicates that the annual percentage change (APC) is significantly different from zero at α=0.05.
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During the study period, the AAPC remained flat 
for most states except California (−2.29 [95% CI, 
−3.86 to −0.69]), New York (−1.64 [95% CI, −2.17 to 
−1.12]), North Carolina (−1.74 [95% CI, −2.94 to −0.53]), 
and Oregon (1.22 [95% CI, 0.11–2.33]) (Table S2). 
However, inflection points were identified in the year 
2010 for Washington (−2.59 [95% CI, −3.89 to −1.28]) 
and Georgia (−3.06 [95% CI, −4.52 to −1.59]); 2012 
and 2013 for North Carolina (−4.07 [95% CI, −5.59 to 
−2.53]) and Virginia (−4.70 [95% CI, −8.34 to −0.91]), 
respectively; 2014 for New York (−5.56 [95% CI, −6.79 
to −4.33]), Arizona (−6.34 [95% CI, −12.15 to −0.15]), 
and Oregon (−3.60 [95% CI, −6.14 to −1.00]); and 2015 
for New Jersey (−6.63 [95% CI, −12.62 to −0.23]). None 
of the states located in the Midwest showed reduction 
in AS mortality (Table S5). Tables S6 to S9 report state-
level mortality rates stratified by sex and race.
Location of Death
Annually, the average absolute number of deaths was 
highest in the inpatient setting (n=6368), followed by 
home (n=4188) and nursing home/long-term care facility 
(n=3190); and lowest in outpatient/emergency depart-
ment (n=671) and hospice facility (n=850). The APC in 
number of deaths increased for outpatient/emergency 
department between 2008 and 2012 (3.6 [95% CI, 
0.3–7.1]), followed by decline between 2012 and 2018 
(−2.9 [95% CI, −4.6 to −1.2]; Figure S6). A similar trend 
was noticed for nursing home/long-term care facility. 
The APC for inpatient deaths initially increased and then 
stabilized since 2015 onwards. The AAPC increased for 
deaths at home (3.3 [95% CI, 2.0–4.5]) and hospice fa-
cility (13.1 [95% CI, 9.7–16.6]), secondary to significant 
growth between 2008 and 2014 for home (5.6 [95% CI, 
4.2–7.1]) and hospice facilities (19.8 [95% CI, 16.4–23.3]).
DISCUSSION
Using contemporary US data, we found some dis-
tinct patterns of AS-related mortality during the past 
10  years. First, urban-rural differences existed, with 
higher burden of mortality in rural than urban areas. 
Second, the mortality varied across states, with higher 
death rates observed in states located in West and 
Northeast, and lower in South. Third, demographic 
disparities were observed at the national and state lev-
els. And fourth, there was an upsurge in the number of 
patients dying at home and hospice facilities.
Figure 4. State-level aortic stenosis–related age-adjusted mortality rates per 100 000 people among adults aged ≥45 years 
in the United States, 2008 to 2018.
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Geographical variations in total and cardiovascular 
mortality in the United States have persisted over the 
years.6,12 In a recent report, rural areas showed greater 
all-cause mortality rates with absolute rural-urban dif-
ferences in AAMR doubling between 1999 and 2017.10 
Our study also illustrated higher AAMRs in rural than 
urban areas. We also identified new hotspots of AS-
related death in states located in West and Northeast 
regions. During the past 5 to 8  years, advancement 
in AS-related life expectancy was observed in states 
substantially clustered outside the Midwest. These 
patterns are partially consistent with overall mortality 
trends in the United States,12 and stem from different 
demographic makeup of the states and their inherent 
disease risk, heterogeneities in metabolic, behavioral, 
and clinical risk factors faced by the state’s resi-
dents,6,12 and access to health care that can modify 
prognosis over time.14
The known risk factors for AS include advanc-
ing age, men, White race, smoking, obesity, hyper-
tension, atherosclerosis, and congenital bicuspid 
valve.2,15 Different degrees of exposure to cardiomet-
abolic risk factors and higher proportions of men and 
White population in certain regions can explain some 
of these trends. For instance, as per the Centers 
for Disease Control and Prevention Behavioral Risk 
Factor Surveillance System surveys, the recent 
prevalence of hypertension and obesity, respec-
tively, in Oregon (30.1% and 29.9%), Vermont (30.4% 
and 27.5%), Washington (29.5% and 28.7%), Maine 
(34.8% and 30.4%), New Hampshire (30.0% and 
29.6%), and Idaho (29.8% and 28.4%) were relatively 
higher than some states located in lower percentile 
for AS-related mortality.16,17 Similarly, some of these 
states (Vermont, Maine, New Hampshire, and Idaho) 
had a higher prevalence of White people than other 
states.18
Similarly, both men and White people had higher 
AAMRs in West and Northeast states compared with 
those in South. Another set of potential explanations 
include socioeconomic pressures and financial hard-
ships that can influence mortality. There was lack of 
AS-related mortality reduction in areas with history 
of economic challenges, such as rural areas19 or the 
industrial Midwest.12 However, mortality decline was 
prominent in states with more robust economies, 
such as California and New York.12 Interplay of so-
cioeconomic predictors, such as income, education 
level, quality of life, exposure to discrimination, and 
employment status between states and residential mi-
norities can shape the mortality trends.6,12,15,20 Finally, 
geographical variation in volume and use of AVR 
procedures, lower density of TAVR programs in rural 
areas, and challenges in accessing therapy can largely 
Figure 5. Sex and age-specific aortic stenosis–related crude mortality rates per 100 000 people in the US regions, 2008 to 2018.
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influence mortality.5 Recently, residents of rural coun-
ties in Florida were shown to travel an extra 44 miles for 
TAVR and experience ≈7-fold lower rates of TAVR pro-
cedures compared with heavily populated regions.15,21
Prior evidence showed that AS-related moral-
ity decline was exclusively limited to patients aged 
≥80  years.1 We document an overall improvement in 
life expectancy in those aged 75 to 84  years during 
the past decade, and reversal of escalating mortal-
ity in those aged >85  years since 2015. These sta-
tistics signal the penetration of therapeutic benefits 
of TAVR in this target population, who may not have 
been candidates for surgical AVR procedures in the 
past. Although reductions in mortality were uniformly 
distributed across sexes, these patterns were not 
observed across race. The national data of inpatient 
hospitalization and Medicare beneficiaries showed 
that Black patients had lower proportion of AS-related 
hospitalizations and received fewer AVR procedures 
than White patients.4,22 The transcatheter valve ther-
apy registry from 2011 to 2016 showed that among 
70  221 patients undergoing TAVR, 91% were White, 
3.8% were Black, 3.4% were Hispanic, and 1.5% were 
Asian/Pacific Islander and American Indian/Alaskan 
Native patients.14 The potential reasons for this imbal-
ance include lower prevalence of AS in non-White pa-
tients compared with White patients,2,15 referral bias for 
AVR favoring White people over other races,23,24 and 
detection bias, where patients belonging to higher-in-
come class were diagnosed more than poor.20 Some 
of these factors might explain reduction in AS mortality 
in White compared with non-White patients.
Location of death is an important component of 
end-of-life care experience.9 Overall proportion of 
AS-related deaths was higher in the inpatient setting. 
However, there was an emerging trend favoring more 
patients dying at home and hospice facilities. The most 
remarkable (≈20%) increase was noticed in patients 
dying at hospice facility. This trend is consistent with 
general population and patients with cardiovascular 
disease,9,25 and reflects the use of palliative care in pa-
tients with debilitating symptoms without cure.
This study has various limitations. Vital statistics and 
census population data rely on death certificates. These 
sources are subject to error because reporting of deaths 
might vary across the states or deaths within the pop-
ulation might be missed or allocated to wrong state.6 
Inaccurate ascertainment of demographic information 
and cause of death based on ICD-10 codes, which 
are subject to misclassification, can bias the results.12 
Analysis of the FHS (Framingham Heart Study) showed 
mismatch between true versus reported causes of 
death in decedents aged >85 years.26 In-hospital mor-
tality rates might be higher because AS is more readily 
diagnosed in the hospital than in those at the time of 
death. This might influence the estimates on location of 
death. The data set lacks the information on prevalence 
of AS or AVR rates. However, although the frequency of 
TAVR has increased, prevalence of AS does not seem to 
have changed over the years.4,14,22,27 Because data were 
missing on pertinent clinical and social determinants of 
health, and regional growth rates of transcatheter or sur-
gical AVR in the United States, the predictors of mortality 
could not be analyzed. Finally, the vital statistic records 
deaths to state of residence at the time of death, and 
does not factor migration between the states.6
In summary, AS-related mortality has reduced in 
the United States during the past 10  years, with the 
decline being more prominent in the second half of 
the decade. However, the downward trend in mortality 
was not consistent among all demographic groups or 
across all the states. The demographic and regional 
variations might have emerged from different clinical 
and social determinants of health among patients. 
Future studies designed to explore underlying clinical 
mechanisms, social disparities, and access to health-
care issues might shed further light to explain commu-
nity-level variations in AS-related mortality.
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Table S1. Aortic Stenosis Related Mortality Stratified by Age in the United States, 2008-2018. 
 
   Crude death rate [95% CI]  
 Number 
of deaths 
Population Overall 45-54 
years 
55-64 
years 
65-74 
years 
75-84 
years 
>85 
years 
Age-adjusted death rate 
[95% CI] 
Entire population 176,743 1,403,676,550 12.6 [12.5, 12.7] 0.6 1.6 5.6 27.8 167.5 12.7 [12.6, 12.8] 
Alabama 1,655 22,056,123 7.5 [7.1, 7.9] 0.5 1.6 4.6 19.8 90.0 8.0 [7.6, 8.4] 
Alaska 286 2,845,879 10.0 [8.9, 11.2]  2.4 7.4 42.9 225.8 17.8 [15.7, 19.9] 
Arizona 3,075 29,120,788 10.6 [10.2, 10.9] 0.6 1.7 4.9 22.5 134.4 10.5 [10.1, 10.8] 
Arkansas 1,319 13,319,205 9.9 [9.4, 10.4] 0.7 1.7 6.1 23.6 113.4 9.9 [9.4, 10.5] 
California 19,163 158,207,289 12.1 [11.9, 12.3] 0.5 1.6 5.0 26.3 169.5 12.5 [12.3, 12.6] 
Colorado 2,151 22,244,085 9.7 [9.3, 10.1] 0.5 1.2 4.9 25.2 152.0 11.4 [10.9, 11.9] 
Connecticut 2,540 17,245,909 14.7 [14.2, 15.3]  1.1 4.5 27.4 187.8 13.1 [12.6, 13.6] 
Delaware 514 4,394,589 11.7 [10.7, 12.7]  1.5 6.0 24.3 164.3 12.0 [11.0, 13.1] 
District of Columbia 205 2,395,956 8.6[7.4, 9.7]    16.2 113.0 8.3 [7.1, 9.4] 
Florida 11,431 98,475,823 11.6 [11.4, 11.8] 0.6 1.6 4.9 21.4 126.6 9.9 [9.8, 10.1] 
Georgia 2,739 41,239,447 6.6 [6.4, 6.9] 0.4 1.5 3.8 19.7 102.4 8.3[8.0, 8.7] 
Hawaii 841 6,401,149 13.1 [12.3, 14.0]  1.9 5.4 22.7 147.0 11.0 [10.3, 11.8] 
Idaho 1,203 6,850,838 17.6[16.6, 18.6]  1.6 5.9 38.8 268.0 18.6 [17.5, 19.6] 
Illinois 6,453 56,123,287 11.5 [11.2, 11.8] 0.4 1.5 5.1 24.8 150.5 11.4 [11.1, 11.7] 
Indiana 3,766 29,044,072 13.0 [12.6, 13.4] 0.6 1.9 6.8 30.3 163.7 13.2[12.8, 13.6] 
Iowa 2,860 14,213,150 20.1 [19.4, 20.9] 0.6 1.6 6.9 34.6 233.9 16.8 [16.2, 17.4] 
Kansas 1,892 12,504,432 15.1 [14.4, 15.8] 0.6 1.5 6.7 31.9 175.1 13.8 [13.1, 14.4] 
Kentucky 1,709 20,006,843 8.5 [8.1, 8.9] 0.5 1.3 5.2 23.4 108.7 9.4 [8.9, 9.8] 
Louisiana 1,762 19,873,936 8.9 [8.5, 9.3] 0.8 1.7 5.5 25.2 109.1 9.9 [9.4, 10.3] 
Maine 1,480 7,049,284 21.0 [19.9, 22.1]  2.1 9.0 46.3 273.4 20.5 [19.5, 21.6] 
Maryland 2,964 26,579,275 11.2 [10.8, 11.6] 0.5 1.3 5.4 27.4 155.2 12.0 [11.5, 12.4] 
Massachusetts 5,215 31,208,510 16.7 [16.3, 17.2] 0.5 1.3 5.0 32.8 217.0 15.3 [14.9, 15.8] 
Michigan 5,857 46,647,612 12.6[12.2, 12.9] 0.5 1.9 5.7 28.6 158.3 12.5 [12.2, 12.8] 
Minnesota 4,348 24,317,043 17.9 [17.3, 18.4] 0.5 1.7 6.4 34.3 241.2 17.0 [16.5, 17.5] 
Mississippi 1,010 12,953,373 7.8 [7.3, 8.3] 0.9 2.1 5.6 20.8 84.6 8.4 [7.9, 8.9] 
Missouri 3,719 27,662,944 13.4 [13.0, 13.9] 0.7 1.5 5.8 29.9 170.1 13.2[12.7, 13.6] 
Montana 813 4,932,827 16.5 [15.3, 17.6]  1.7 6.6 36.2 218.8 16.3 [15.1, 17.4] 
Nebraska 1,456 8,113,061 17.9 [17.0, 18.9] 0.8 1.8 5.6 32.5 221.2 15.8 [15.0, 16.7] 
Nevada 992 12,159,773 8.2 [7.7, 8.7] 0.5 1.6 5.5 22.0 126.7 10.1 [9.5, 10.7] 
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New Hampshire 1,175 6,695,032 17.6 [16.5, 18.6]  1.8 7.4 42.9 251.2 18.7 [17.6, 19.8] 
New Jersey 6,143 41,147,745 14.9 [14.6, 15.3] 0.5 1.4 5.5 29.7 199.6 14.3 [13.9, 14.7] 
New Mexico 752 9,272,492 8.1 [7.5, 8.7]  1.8 4.2 20.2 99.9 8.5 [7.9, 9.1] 
New York 10,213 88,664,277 11.5 [11.3, 11.7] 0.3 1.1 4.2 22.9 149.2 10.8 [10.6, 11.0] 
North Carolina 5,160 43,970,232 11.7 [11.4, 12.1] 0.6 1.6 6.0 28.7 165.0 12.8 [12.5, 13.2] 
North Dakota 447 3,111,774 14.4 [13.0, 15.7]   5.5 26.7 152.8 11.9 [10.8, 13.1] 
Ohio 7,423 54,207,144 13.7 [13.4, 14.0] 0.6 1.7 6.6 30.4 167.2 13.3 [13.0, 13.6] 
Oklahoma 1,549 16,631,544 9.3 [8.8, 9.8] 0.5 1.6 5.6 23.1 110.7 9.6 [9.1, 10.0] 
Oregon 4,990 18,310,826 27.3 [26.5, 28.0] 0.8 2.6 9.0 58.1 370.2 26.6 [25.9, 27.4] 
Pennsylvania 12,138 62,073,610 19.6 [19.2, 19.9] 0.7 1.6 6.6 37.8 229.9 17.0 [16.7, 17.3] 
Rhode Island 742 5,014,440 14.8 [13.7, 15.9]   5.0 27.9 168.3 12.6 [11.7, 13.6] 
South Carolina 2,431 22,071,803 11.0 [10.6, 11.5] 0.7 1.9 5.6 26.4 159.2 12.3 [11.8, 12.8] 
South Dakota 590 3,782,478 15.6 [14.3, 16.9]   5.1 33.4 172.3 13.4 [12.3, 14.5] 
Tennessee 3,167 29,542,896 10.7 [10.3, 11.1] 0.8 1.9 6.1 27.9 139.6 11.7 [11.3, 12.2] 
Texas 7,998 102,454,518 7.8 [7.6, 8.0] 0.5 1.5 5.2 21.8 109.5 9.2 [9.0, 9.4] 
Utah 887 9,482,591 9.4 [8.7, 10.0] 0.6 1.7 5.3 23.1 133.0 10.6 [9.9, 11.3] 
Vermont 769 3,191,207 24.1 [22.4, 25.8]  2.0 9.4 50.8 344.1 24.3 [22.6, 26.0] 
Virginia 4,026 36,367,503 11.1 [10.7, 11.4] 0.5 1.4 5.5 28.0 162.5 12.4 [12.0, 12.8] 
Washington 6,333 30,878,750 20.5 [20.0, 21.0] 0.8 2.2 8.7 47.5 296.9 21.8 [21.3, 22.4] 
West Virginia 1,042 9,292,823 11.2 [10.5, 11.9] 1.4 2.6 5.8 28.2 120.0 11.3 [10.6, 11.9] 
Wisconsin 5,024 26,766,339 18.8 [18.3, 19.3] 0.6 1.7 6.8 38.2 246.9 17.9 [17.4, 18.3] 
Wyoming 326 2,560,024 12.7 [11.4, 14.1]   7.4 33.2 172.2 14.0 [12.5, 15.6] 
Sex 
Women 102,084 743,730,147 13.7 [13.6, 13.8] 0.3 1.1 4.6 25.1 162.1 11.7 [11.6, 11.8] 
Men 74,659 659,946,403 11.3 [11.2, 11.4] 0.8 2.1 6.7 31.3 177.9 14.1 [13.9, 14.2] 
Race 
Whites 165,999 1,162,397,579 14.3 [14.2, 14.4] 0.6 1.7 5.9 29.9 180.6 13.7 [13.6, 13.7] 
Blacks 7,510 157,593,908 4.8 [4.7, 4.9] 0.7 1.7 4.4 15.3 63.0 6.3 [6.2, 6.4] 
Asians or Pacific Islanders 2,646 69,817,576 3.8 [3.6, 3.9] 0.2 0.6 2.3 10.8 68.1 5.1 [4.9, 5.3[ 
American Indians or Alaska Natives 588 13,867,487 4.2 [3.9, 4.6] 0.7 1.6 5 18.0 64.0 6.8 [6.2, 7.4] 
Hispanics 6,366 146,749,567 4.3 [4.2, 4.4] 0.4 1.3 3.9 16.6 71.3 6.5 [6.4, 6.7] 
Displayed is the total population and number of aortic-stenosis related deaths in each state between 2008 and 2018. The colors represent the value of the 
observed age-adjusted mortality rates per 100,000 persons, ranging from green (lowest) to red (highest). Cells are empty if no data were available. 
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Table S2. Trends in Age-Adjusted Aortic Stenosis-Related Mortality Rates in the United States, 2008-2018. 
 
 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 AAPC [95% CI] 
Entire population 12.7 12.8 13.0 12.8 12.9 13.3 13.2 13.0 12.5 12.1 11.5  
Alabama 8.6 8.8 9.2 8.1 8.4 8.6 9.1 7.6 6.4 7.7 6.5 -2.96 [-6.16, 0.35] 
Alaska  17.5 22.3 21.5 16.0 19.6 18.9 20.2 19.8  15.7 44.71 [-70.05, 599.3] 
Arizona 10.6 10.7 10.6 11.9 10.1 11.7 11.3 10.7 10.0 9.8 8.5 -1.84 [-4.39, 0.77] 
Arkansas 9.4 8.1 10.4 9.3 11.0 10.9 10.8 9.5 9.6 10.7 9.4 0.82 [-3.17, 4.97] 
California 13.4 13.5 13.5 12.5 12.8 13.2 12.3 12.4 12.3 11.3 10.8 -2.29* [-3.86, -0.69] 
Colorado 10.0 12.1 11.1 12.6 12.1 11.7 12.2 10.8 11.7 11.4 10.1 0.23 [-2.92, 3.48] 
Connecticut 14.7 12.3 15.9 13.4 12.8 11.2 13.7 13.4 12.9 12.3 11.8 -1.5 [-4.97, 2.11] 
Delaware 12.8 11.5 9.9 11.6 10.5 12.6 15.5 9.8 12 11.4 14.2 0.22 [-8.91, 10.27] 
District of Columbia     9.0  9.9   10 8.6  
Florida 10.8 10.4 10.3 9.5 10.4 9.8 11.0 10.0 9.8 9.2 8.8 -1.64 [-4.07, 0.86] 
Georgia 9.1 8.5 10.0 8.7 8.6 8.3 8.3 8.5 7.9 7.7 6.9 -1.87 [-4.22, 0.53] 
Hawaii 9.7 11.9 8.5 10.3 13.9 14.6 8.5 11.7 11.0 10.1 11.3 0.88 [-7.17, 9.64] 
Idaho 18.8 17.3 20.3 16.5 17.8 19.9 19.5 18.1 21.4 18.3 16.5 -0.73 [-5.26, 4.02] 
Illinois 11.1 11.1 11.3 11.5 11.2 11.9 12.3 11.6 11.5 11.8 9.8 -0.89 [-2.4, 0.66] 
Indiana 13.1 11.9 12.6 14.0 13.7 14.1 12.9 13.9 13.3 13.3 12.3 0.2 [-2.11, 2.56] 
Iowa 16.4 15.1 15.4 15.4 15.4 18.3 16.0 18.7 18.7 16.7 18.4 1.47 [-2.91, 6.05] 
Kansas 11.3 14.7 15.8 12.0 11.5 15.0 14.8 13.8 14.1 15.2 13.1 1.5 [-4.34, 7.69] 
Kentucky 7.4 8.1 9.0 10.4 10.0 9.7 9.0 9.7 11.0 9.9 8.5 2.47 [-1.45, 6.54] 
Louisiana 10.8 11.9 10.9 9.3 9.0 10.1 9.2 9.8 8.6 10.3 9.0 -2.05 [-5.58, 1.62] 
Maine 19.3 18 17.2 17.8 20.3 18.8 20.2 23.3 27.5 19.3 23.3 2.34 [-5.08, 10.33] 
Maryland 12.3 12.2 12.3 11.7 12.2 12.3 12.4 11.3 11.3 12.4 11.5 -0.45 [-2.34, 1.48] 
Massachusetts 15.4 15.7 15.8 15.7 14.8 17.1 15.0 16.0 15.7 14.0 13.6 -1.53 [-4.3, 1.32] 
Michigan 12.5 11.3 12.2 11.6 12.5 12.2 13.3 13.7 13.5 12.4 12.2 0.35 [-2.61, 3.39] 
Minnesota 16.4 16.6 17.3 16.1 16.9 17.5 17.0 18 17.9 16.3 16.5 -0.13 [-1.84, 1.61] 
Mississippi 8.2 7.4 8.7 7.2 9.4 8.7 9.2 9.3 7.4 8.8 7.5 -0.03 [-4.81, 5] 
Missouri 11.5 13.2 12.5 14.1 13.8 12.9 14.8 13.9 13.7 12.4 11.8 -0.11 [-2.57,2.4] 
Montana 14.2 10.8 18.4 20.3 17.2 17.3 16.1 15.7 16.3 15.2 16.9 2.19 [-4.63, 9.5] 
Nebraska 12.7 14.8 14.9 14.8 18.0 17.0 19.2 17.0 15.2 15.0 15.3 0.84 [-1.76, 3.51] 
Nevada 13.5 7.8 11.2 9.7 9.9 8.0 8.8 11.5 11.2 11.2 8.7 -0.48 [-8.58, 8.34] 
New Hampshire 15.2 18.8 22.0 17.8 20.0 18.8 19.1 18.4 18.3 17.8 19.2 1.42 [-1.18, 4.09] 
New Jersey 15.0 13.6 14.1 14.6 15.0 14.4 15.5 15.4 13.9 13.1 12.5 -1.37 [-3.2, 0.5] 
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New Mexico 8.2 8.8 10.0 8.1 9.9 9.7 8.2 9.5 8.2 6.9 6.4 -3.27 [-7.7, 1.37] 
New York 11.1 11.2 11.3 11.4 11.6 11.6 10.9 10.1 9.7 9.4 11.1 -1.64* [-2.17, -1.12] 
North Carolina 13.3 13.9 12.8 13.6 14.5 13.7 13.2 12.6 11.8 11.7 10.9 -1.74* [-2.94, -0.53] 
North Dakota 12.8 11.9 10.8 11.1 12.5 8.5 9.0 12.8 17.4 12.4 12.0 1.12 [-6.84, 9.77] 
Ohio 13.8 13.2 12.8 13.9 13.0 13.3 14.3 13.8 12.8 12.9 12.4 -0.73 [-2.63, 1.2] 
Oklahoma 10.0 11.5 10.1 10.5 9.6 9.5 9.9 7.9 9.5 9.9 7.3 -2.98 [-7.48, 1.74] 
Oregon 23.4 23.6 24.8 25.6 26.5 29.2 30.8 28.5 27.1 26.1 26.5 1.22* [0.11, 2.33] 
Pennsylvania 16.4 16.8 17.1 17.4 16.7 18.1 16.9 17.7 17.1 16.5 16.3 -0.28 [-1.63, 1.09] 
Rhode Island 13.0 10.2 11.4 11.8 13.5 13.9 14.0 11.0 12.1 13.8 13.5 1.35 [-3.8, 6.77] 
South Carolina 12.9 13.0 12.0 12.8 12.1 12.5 12.1 12.5 12.3 11.7 11.5 -1.06 [-2.82, 0.73] 
South Dakota 13.1 12.8 15.0 11.5 12.2 15.6 10.9 15.5 13.8 13.6 13.4 0.36 [-5.79, 6.91] 
Tennessee 10.2 10.6 11.4 12.1 12.9 13.2 12.9 11.7 10.8 11.8 11.4 1.02 [-1.02, 3.1] 
Texas 9.5 9.8 9.7 9.3 9.5 9.9 9.5 9.0 8.3 9.1 8.5 -1.25 [-2.89, 0.41] 
Utah 11.1 9.7 12.3 11.2 9.7 11.3 10.4 11.6 10.7 9.0 9.9 -1.37 [-5.97, 3.45] 
Vermont 22.3 25.8 17.9 27.5 30.0 29.1 23.5 22.1 22.9 25.9 20.0 -0.03 [-7.02, 7.49] 
Virginia 11.9 12.7 13.1 12.7 13.6 13.6 13.1 12.7 10.8 12.0 10.7 -1.24 [-3.4, 0.96] 
Washington 21.1 23.0 24.9 23.0 21.6 23.2 21.6 22.2 20.9 20.0 19.3 -0.78 [-2.89, 1.37] 
West Virginia 11.9 11.8 8.9 12.0 12.1 13.5 10.9 13.1 10.5 10.6 8.8 -2.01 [-8.12, 4.5] 
Wisconsin 15.3 17.0 17.3 16.7 17.3 18.5 18.1 20.1 19.3 18.3 17.9 1.3 [-0.33, 2.96] 
Wyoming 15.5 17.5 14.7 15.1 11.1 16.1 12.9 11.5 18.3 13.0 9.4 -4.24 [-11.67, 3.82] 
Sex 
Women 11.8 11.9 12.1 11.8 11.9 12.1 12.1 12.0 11.5 11.3 10.7 -1.0 [-1.5, -0.4] 
Men 14.1 14.0 14.3 14.4 14.5 14.9 14.7 14.3 13.9 13.2 12.6 -1.0 [-1.4, -0.6] 
Race 
Whites 13.6 13.7 14.1 14.1 14.4 15.0 14.9 15.0 14.5 14.1 13.5 -0.8 [-1.2, -0.4] 
Blacks 4.6 4.7 4.6 4.6 4.3 4.8 5.3 4.6 4.8 4.9 5.0 -0.4 [-1.4, 0.7] 
Asians or Pacific Islanders 3.2 3.6 3.3 3.8 3.8 4.3 3.8 4 4.1 3.8 3.8 -1.1 [-3.0, 0.9] 
American Indians or Alaska Natives 8.4 6.9 6.2 8.1 7.5 6.7 7.9 6.3 5.8 5.5 6.7 -2.5 [-7.6, 2.8] 
Hispanics 6.3 7.0 7.0 5.8 6.6 7.0 6.9 6.7 6.3 6.4 6.0 -0.7 [-3.8, 2.5] 
Observed age-adjusted mortality rates are reported for individual states and for the entire population between 2008 and 2018. The colors represent the value of 
the observed age-adjusted mortality rates per 100,000 persons, ranging from green (lowest) to red (highest). Cells are empty if no data were available. AAPC 
stands for Average Annual Percentage Change. Indicates that the Annual Percent Change (APC) is significantly different from zero at the alpha = 0.05 
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Table S3. Absolute Number of Aortic Stenosis Related Deaths Stratified by Sex and Race in 
the United States, 2008-2018. 
 
Year Women Men Whites Blacks Asians/PI AI/AN Hispanics Total Population 
2008 8440 5818 13468 582 160 48 411 117395131 
2009 8680 5966 13804 610 189 43 472 119895863 
2010 9014 6192 14371 618 179 38 492 121757429 
2011 8994 6518 14613 632 216 51 449 124174484 
2012 9260 6770 15132 611 231 56 535 126000296 
2013 9640 7209 15839 688 271 51 613 127788037 
2014 9747 7306 15972 772 250 59 638 129779643 
2015 9891 7351 16226 686 275 55 675 131826832 
2016 9627 7335 15874 741 291 56 670 133494018 
2017 9585 7170 15634 772 289 60 710 135229289 
2018 9206 7024 15066 798 295 71 701 136335528 
AI/AN = American Indians or Alaska Natives; PI = Pacific Islanders 
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Table S4. Aortic Stenosis Related Mortality Stratified by States in the United States, 2008-2018. 
 
States Rank Percentile AAMR per 100,000 
Oregon 1 100.00% 26.6 
Vermont 2 98.00% 24.3 
Washington 3 96.00% 21.8 
Maine 4 94.00% 20.5 
New Hampshire 5 92.00% 18.7 
Idaho 6 90.00% 18.6 
Wisconsin 7 88.00% 17.9 
Alaska 8 86.00% 17.8 
Minnesota 9 82.00% 17.0 
Pennsylvania 9 82.00% 17.0 
Iowa 11 80.00% 16.8 
Montana 12 78.00% 16.3 
Nebraska 13 76.00% 15.8 
Massachusetts 14 74.00% 15.3 
New Jersey 15 72.00% 14.3 
Wyoming 16 70.00% 14.0 
Kansas 17 68.00% 13.8 
South Dakota 18 66.00% 13.4 
Ohio 19 64.00% 13.3 
Indiana 20 60.00% 13.2 
Missouri 20 60.00% 13.2 
Connecticut 22 58.00% 13.1 
North Carolina 23 56.00% 12.8 
Rhode Island 24 54.00% 12.6 
California 25 50.00% 12.5 
Michigan 25 50.00% 12.5 
Virginia 27 48.00% 12.4 
South Carolina 28 46.00% 12.3 
Delaware 29 42.00% 12.0 
Maryland 29 42.00% 12.0 
North Dakota 31 40.00% 11.9 
Tennessee 32 38.00% 11.7 
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Colorado 33 34.00% 11.4 
Illinois 33 34.00% 11.4 
West Virginia 35 32.00% 11.3 
Hawaii 36 30.00% 11.0 
New York 37 28.00% 10.8 
Utah 38 26.00% 10.6 
Arizona 39 24.00% 10.5 
Nevada 40 22.00% 10.1 
Arkansas 41 16.00% 9.9 
Florida 41 16.00% 9.9 
Louisiana 41 16.00% 9.9 
Oklahoma 44 14.00% 9.6 
Kentucky 45 12.00% 9.4 
Texas 46 10.00% 9.2 
New Mexico 47 8.00% 8.5 
Mississippi 48 6.00% 8.4 
District of Columbia 49 2.00% 8.3 
Georgia 49 2.00% 8.3 
Alabama 51 0.00% 8.0 
States are arranged based on percentile ranked from highest to lowest age adjusted mortality rates (AAMR) per 100,000 persons. 
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Table S5. State-Wise Trends in Aortic Stenosis Related Mortality in the United States, 2008-2018. 
 
States Joinpoint year APC 95% Confidence interval P-value 
Alabama  
 
2008 2014 -0.67 -4.91 3.77 0.72 
2014 2018 -6.3 -13.65 1.68 0.10 
Alaska  
 
2008 2010 4255.46 -99.47 35739896 0.35 
2010 2018 -38.22 -76.89 65.17 0.28 
Arizona     
   
2008 2014 1.28 -2.13 4.8 0.40 
2014 2018 -6.34* -12.15 -0.15 0.05 
Arkansas  
 
2008 2013 4.11 -3.04 11.8 0.22 
2013 2018 -2.37 -9.08 4.84 0.44 
California     
  
2008 2016 -1.25* -2.25 -0.25 0.02 
2016 2018 -6.33 -14.64 2.79 0.14 
Colorado  
 
2008 2011 6.26 -5.06 18.92 0.24 
2011 2018 -2.25 -5.14 0.74 0.11 
Connecticut  
 
2008 2013 -2.43 -8.43 3.96 0.38 
2013 2018 -0.55 -6.66 5.97 0.84 
Delaware  
 
2008 2010 -8.11 -46.8 58.7 0.72 
2010 2018 2.42 -3.51 8.72 0.36 
District of Columbia  
 
2008 2016     
2016 2018     
Florida  
 
2008 2015 -0.32 -2.66 2.06 0.75 
2015 2018 -4.63 -12.71 4.2 0.24 
Georgia  
 
2008 2010 3.02 -10.31 18.34 0.62 
2010 2018 -3.06* -4.52 -1.59 <0.01 
Hawaii  
 
2008 2012 5.91 -13.52 29.71 0.51 
2012 2018 -2.34 -12.36 8.84 0.61 
Idaho  
 
2008 2016 1.31 -1.6 4.31 0.32 
2016 2018 -8.49 -29.95 19.55 0.45 
Illinois     
 
2008 2016 1.02* 0.06 2 0.04 
2016 2018 -8.17 -15.92 0.3 0.06 
Indiana  
 
2008 2013 2.34 -1.78 6.63 0.22 
2013 2018 -1.9 -5.85 2.22 0.30 
Iowa  
 
2008 2010 -2.29 -24.1 25.79 0.83 
2010 2018 2.44 -0.35 5.3 0.08 
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Kansas  
 
2008 2010 7.52 -23.38 50.88 0.62 
2010 2018 0.05 -3.58 3.82 0.97 
Kentucky     
 
2008 2011 11.35 -2.96 27.78 0.10 
2011 2018 -1.12 -4.69 2.59 0.48 
Louisiana  
 
2008 2012 -4.98 -13.11 3.92 0.21 
2012 2018 -0.05 -4.72 4.85 0.98 
Maine  
 
2008 2010 -3.84 -37.48 47.88 0.83 
2010 2018 3.94 -0.83 8.94 0.09 
Maryland  
 
2008 2016 -0.66 -1.84 0.54 0.22 
2016 2018 0.4 -10.02 12.03 0.93 
Massachusetts  
 
2008 2016 0.08 -1.69 1.88 0.92 
2016 2018 -7.71 -21.6 8.64 0.27 
Michigan  
 
2008 2016 1.78 -0.1 3.7 0.06 
2016 2018 -5.19 -20.08 12.47 0.47 
Minnesota  
 
2008 2016 0.95 -0.13 2.04 0.08 
2016 2018 -4.31 -13.32 5.63 0.32 
Mississippi  
 
2008 2014 2.81 -3.55 9.59 0.33 
2014 2018 -4.13 -14.93 8.03 0.42 
Missouri     
 
2008 2014 3.15 -0.14 6.55 0.06 
2014 2018 -4.82 -10.42 1.13 0.09 
Montana  
 
2008 2011 13.94 -10.73 45.41 0.24 
2011 2018 -2.47 -8.62 4.1 0.38 
2012 2018 -0.05 -4.72 4.85 0.98 
Nebraska     
  
2008 2014 5.64* 2.11 9.29 0.01 
2014 2018 -5.95 -11.74 0.23 0.06 
Nevada  
 
2008 2013 -4.02 -17.38 11.49 0.53 
2013 2018 3.2 -11.16 19.89 0.63 
New Hampshire     
 
2008 2010 13.62 -2.07 31.84 0.08 
2010 2018 -1.42 -3 0.19 0.07 
New Jersey     
 
2008 2015 0.98 -0.79 2.79 0.23 
2015 2018 -6.63* -12.62 -0.23 0.04 
New Mexico     
 
2008 2015 0.88 -3.49 5.44 0.65 
2015 2018 -12.3 -25.67 3.48 0.10 
New York     
 
2008 2014 1.06* 0.36 1.77 0.01 
2014 2018 -5.56* -6.79 -4.33 <0.01 
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North Carolina     
 
2008 2012 1.86 -1.14 4.94 0.18 
2012 2018 -4.07* -5.59 -2.53 <0.01 
North Dakota  
 
2008 2013 -4.55 -17.42 10.32 0.46 
2013 2018 7.13 -7.31 23.83 0.29 
Ohio  
 
2008 2015 0.39 -1.42 2.23 0.62 
2015 2018 -3.29 -9.66 3.52 0.27 
Oklahoma  
 
2008 2016 -1.92 -4.79 1.03 0.16 
2016 2018 -7.11 -29.22 21.91 0.53 
Oregon     
 
2008 2014 4.56* 3.08 6.07 <0.01 
2014 2018 -3.60* -6.14 -1.00 0.02 
Pennsylvania  
 
2008 2015 0.8 -0.49 2.1 0.18 
2015 2018 -2.74 -7.32 2.07 0.21 
Rhode Island  
 
2008 2013 2.75 -6.28 12.64 0.50 
2013 2018 -0.03 -8.82 9.6 0.99 
South Carolina  
 
2008 2016 -0.55 -1.66 0.57 0.27 
2016 2018 -3.06 -12.53 7.43 0.49 
South Dakota  
 
2008 2011 -1.6 -21.3 23.02 0.87 
2011 2018 1.21 -4.65 7.44 0.64 
Tennessee     
 
2008 2012 6.70* 1.53 12.13 0.02 
2012 2018 -2.59 -5.14 0.03 0.05 
Texas  
 
2008 2013 0.01 -2.9 3 1.00 
2013 2018 -2.49 -5.33 0.43 0.08 
Utah  
 
2008 2015 0.21 -4.21 4.82 0.91 
2015 2018 -4.96 -19.71 12.48 0.49 
Vermont  
 
2008 2012 6.79 -10.49 27.41 0.40 
2012 2018 -4.33 -12.94 5.14 0.29 
Virginia     
 
2008 2013 2.34 -1.57 6.41 0.20 
2013 2018 -4.70* -8.34 -0.91 0.02 
Washington     
  
2008 2010 6.79 -5.56 20.76 0.24 
2010 2018 -2.59* -3.89 -1.28 <0.01 
West Virginia  
 
2008 2015 1.69 -4.3 8.05 0.53 
2015 2018 -10.13 -28.39 12.79 0.29 
Wisconsin     
    
2008 2015 3.06* 1.49 4.65 <0.01 
2015 2018 -2.69 -8.11 3.05 0.29 
Wyoming  2008 2016 -0.99 -5.86 4.13 0.65 
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 2016 2018 -16.2 -47.21 33.04 0.39 
APC (Annual Percent Change) in Age Adjusted Mortality Rates. Cells are empty if no data were available.  
*Indicates that the Annual Percent Change (APC) is significantly different from zero at the alpha = 0.05 
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Table S6. Aortic Stenosis Related Mortality Stratified by State and Sex in the United States, 2008-2018. 
 
 Females Males 
State Death Population Crude rate AAMR Death Population Crude rate AAMR 
Alabama 933 11,844,702 7.9 7.3 722 10,211,421 7.1 9.1 
Alaska 152 1,382,156 11 16.7 134 1,463,723 9.2 19.1 
Arizona 1,681 15,288,108 11 9.9 1,394 13,832,680 10.1 11.2 
Arkansas 741 7,062,057 10.5 9.1 578 6,257,148 9.2 11.1 
California 10,614 83,199,489 12.8 11.3 8,549 75,007,800 11.4 14.2 
Colorado 1,226 11,542,066 10.6 10.6 925 10,702,019 8.6 12.5 
Connecticut 1,574 9,230,427 17.1 12.5 966 8,015,482 12.1 13.9 
Delaware 299 2,359,700 12.7 11.3 215 2,034,889 10.6 12.8 
District of Columbia 119 1,301,760 9.1 7.2 86 1,094,196 7.9 9.8 
Florida 6,152 52,429,018 11.7 9 5,279 46,046,805 11.5 11.3 
Georgia 1,582 22,066,010 7.2 7.7 1,157 19,173,437 6 9.3 
Hawaii 471 3,345,418 14.1 10.1 370 3,055,731 12.1 12.4 
Idaho 688 3,524,297 19.5 17.7 515 3,326,541 15.5 19.5 
Illinois 3,833 29,869,677 12.8 10.5 2,620 26,253,610 10 12.6 
Indiana 2,217 15,358,987 14.4 12.3 1,549 13,685,085 11.3 14.5 
Iowa 1,715 7,458,861 23 15.6 1,145 6,754,289 17 18.6 
Kansas 1,135 6,571,422 17.3 13.1 757 5,933,010 12.8 14.5 
Kentucky 973 10,605,060 9.2 8.6 736 9,401,783 7.8 10.7 
Louisiana 999 10,601,950 9.4 9.1 763 9,271,986 8.2 11 
Maine 884 3,714,139 23.8 19.6 596 3,335,145 17.9 21.6 
Maryland 1,754 14,330,151 12.2 11.2 1,210 12,249,124 9.9 13.2 
Massachusetts 3,146 16,755,289 18.8 14.2 2,069 14,453,221 14.3 17.1 
Michigan 3,344 24,645,035 13.6 11.3 2,513 22,002,577 11.4 14.1 
Minnesota 2,504 12,649,473 19.8 15.3 1,844 11,667,570 15.8 19.2 
Mississippi 572 6,973,847 8.2 7.7 438 5,979,526 7.3 9.4 
Missouri 2,155 14,690,232 14.7 12 1,564 12,972,712 12.1 14.7 
Montana 441 2,528,598 17.4 14.6 372 2,404,229 15.5 18.1 
Nebraska 886 4,245,386 20.9 14.9 570 3,867,675 14.7 16.7 
Nevada 532 6,191,923 8.6 9.5 460 5,967,850 7.7 10.8 
New Hampshire 700 3,485,057 20.1 17.7 475 3,209,975 14.8 19.8 
New Jersey 3,779 22,098,302 17.1 13.6 2,364 19,049,443 12.4 15.3 
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New Mexico 389 4,883,677 8 7.5 363 4,388,815 8.3 9.8 
New York 6,190 47,855,034 12.9 10.1 4,023 40,809,243 9.9 11.8 
North Carolina 3,008 23,598,160 12.7 11.8 2,152 20,372,072 10.6 14.3 
North Dakota 260 1,599,349 16.3 11 187 1,512,425 12.4 13.2 
Ohio 4,286 28,854,577 14.9 12.1 3,137 25,352,567 12.4 15 
Oklahoma 893 8,775,760 10.2 9.1 656 7,855,784 8.4 10.2 
Oregon 2,913 9,591,034 30.4 25.3 2,077 8,719,792 23.8 28.3 
Pennsylvania 7,488 33,132,629 22.6 16.2 4,650 28,940,981 16.1 18.1 
Rhode Island 436 2,707,595 16.1 11.1 306 2,306,845 13.3 14.9 
South Carolina 1,389 11,852,022 11.7 11.2 1,042 10,219,781 10.2 13.8 
South Dakota 355 1,954,751 18.2 12.9 235 1,827,727 12.9 14.2 
Tennessee 1,798 15,771,813 11.4 10.6 1,369 13,771,083 9.9 13.3 
Texas 4,358 53,782,694 8.1 8.3 3,640 48,671,824 7.5 10.5 
Utah 469 4,889,122 9.6 9.7 418 4,593,469 9.1 11.8 
Vermont 467 1,670,267 28 23.3 302 1,520,940 19.9 25.3 
Virginia 2,272 19,301,699 11.8 11.2 1,754 17,065,804 10.3 14.3 
Washington 3,583 16,057,105 22.3 20.1 2,750 14,821,645 18.6 24.2 
West Virginia 584 4,879,261 12 10.3 458 4,413,562 10.4 12.4 
Wisconsin 2,977 13,934,494 21.4 16.6 2,047 12,831,845 16 19.6 
Wyoming 168 1,290,507 13 12.4 158 1,269,517 12.4 16.2 
Crude death rates and AAMR (age adjusted mortality rates) are calculated per 100,000 persons 
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Table S7. Aortic Stenosis Related Mortality Stratified by State and Race (White and Blacks) in the United States, 2008-2018. 
 
 Whites Blacks 
State Death Population Crude rate AAMR Death Population Crude rate AAMR 
Alabama 1,442 16,714,244 8.6 8.7 205 4,972,571 4.1 5.1 
Alaska 221 2,186,767 10.1 17.8     
Arizona 2,973 26,158,455 11.4 10.8 25 1,021,291 2.4 3.8 
Arkansas 1,229 11,389,687 10.8 10.4 81 1,673,582 4.8 6.4 
California 17,403 120,664,334 14.4 14.2 620 10,325,897 6 7.8 
Colorado 2,095 20,501,255 10.2 11.8 23 821,760 2.8 4.6 
Connecticut 2,484 15,161,778 16.4 13.8 49 1,498,073 3.3 4.8 
Delaware 469 3,448,923 13.6 12.8 43 801,930 5.4 8 
District of Columbia 89 870,595 10.2 10.2 112 1,443,316 7.8 7.2 
Florida 10,849 83,748,843 13 10.4 517 11,939,979 4.3 5.6 
Georgia 2,363 28,526,306 8.3 9.4 361 11,230,821 3.2 4.9 
Hawaii 266 1,944,422 13.7 15.3     
Idaho 1,187 6,628,966 17.9 18.7     
Illinois 6,061 46,016,729 13.2 12.3 330 7,346,812 4.5 5.5 
Indiana 3,641 26,390,868 13.8 13.6 116 2,179,728 5.3 6.6 
Iowa 2,844 13,731,462 20.7 16.9 13 265,997 Unreliable Unreliable 
Kansas 1,830 11,518,178 15.9 14 42 613,929 6.8 9.2 
Kentucky 1,648 18,452,000 8.9 9.6 54 1,316,562 4.1 5.6 
Louisiana 1,483 13,939,082 10.6 10.9 265 5,506,109 4.8 6.3 
Maine 1,474 6,908,742 21.3 20.6     
Maryland 2,605 17,667,840 14.7 13.9 336 7,291,427 4.6 6.6 
Massachusetts 5,093 27,797,292 18.3 16.1 89 1,943,959 4.6 6.7 
Michigan 5,565 39,893,561 13.9 13.3 251 5,505,925 4.6 5.3 
Minnesota 4,258 22,682,749 18.8 17.1 47 791,969 5.9 12.2 
Mississippi 832 8,735,247 9.5 9.3 176 4,053,762 4.3 5.6 
Missouri 3,542 24,493,388 14.5 13.6 161 2,634,538 6.1 7.9 
Montana 797 4,672,939 17.1 16.4     
Nebraska 1,435 7,654,822 18.7 16.1 14 279,090 Unreliable Unreliable 
Nevada 917 9,892,298 9.3 10.9 33 940,061 3.5 4.9 
New Hampshire 1,173 6,510,539 18 18.9     
New Jersey 5,829 32,618,916 17.9 15.6 244 5,199,384 4.7 6.3 
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New Mexico 715 8,200,201 8.7 8.8     
New York 9,731 67,345,461 14.4 12.4 382 14,013,368 2.7 3.3 
North Carolina 4,596 33,998,283 13.5 13.9 520 8,619,300 6 7.9 
North Dakota 442 2,959,151 14.9 12     
Ohio 7,081 47,662,263 14.9 14 321 5,614,956 5.7 6.8 
Oklahoma 1,414 14,050,153 10.1 9.7 47 1,056,192 4.4 6.5 
Oregon 4,882 17,066,988 28.6 27.1 30 287,554 10.4 17.2 
Pennsylvania 11,733 54,988,198 21.3 17.8 367 5,544,650 6.6 7.9 
Rhode Island 732 4,602,020 15.9 13.1     
South Carolina 2,080 16,356,767 12.7 13.3 344 5,344,755 6.4 8.3 
South Dakota 575 3,524,134 16.3 13.5     
Tennessee 2,936 25,010,476 11.7 12.3 225 4,049,561 5.6 7.6 
Texas 7,401 85,757,292 8.6 9.7 500 11,539,602 4.3 6.4 
Utah 865 8,987,994 9.6 10.7     
Vermont 769 3,128,486 24.6 24.6     
Virginia 3,593 27,727,837 13 13.6 394 6,559,341 6 7.9 
Washington 6,075 27,051,023 22.5 22.8 72 980,337 7.3 12.7 
West Virginia 1,019 8,941,744 11.4 11.3 21 272,907 7.7 9.1 
Wisconsin 4,940 25,051,942 19.7 18.2 52 1,138,990 4.6 7.2 
Wyoming 323 2,465,939 13.1 14.3     
Crude death rates and AAMR (age adjusted mortality rates) are calculated per 100,000 persons. Cells are empty if no data were available. 
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Table S8. Aortic Stenosis Related Mortality Stratified by State and Race (Asian/Pacific Islander and American Indian/Alaska 
Native) in the United States, 2008-2018. 
 
 Asian/Pacific Islander American Indian/Alaska Native 
State Death Population Crude rate AAMR Death Population Crude rate AAMR 
Alabama         
Alaska     50 378,215 13.2 22.6 
Arizona 29 847,302 3.4 5.1 48 1,093,740 4.4 5.7 
Arkansas         
California 1,068 24,881,969 4.3 4.9 72 2,335,089 3.1 5 
Colorado 21 624,039 3.4 5.2 12 297,031 Unreliable Unreliable 
Connecticut         
Delaware         
District of Columbia         
Florida 59 2,379,610 2.5 3.8     
Georgia 15 1,320,159 Unreliable Unreliable     
Hawaii 15 1,320,159 Unreliable Unreliable     
Idaho         
Illinois 61 2,507,737 2.4 3.7     
Indiana         
Iowa         
Kansas     13 125,263 Unreliable Unreliable 
Kentucky         
Louisiana         
Maine         
Maryland 21 1,497,686 1.4 2.3     
Massachusetts 30 1,348,548 2.2 3.4     
Michigan 18 934,789 Unreliable Unreliable 23 313,337 7.3 11.1 
Minnesota 23 615,308 3.7 6 20 227,017 8.8 13.3 
Mississippi         
Missouri 12 379,943 Unreliable Unreliable     
Montana     14 214,124 Unreliable Unreliable 
Nebraska         
Nevada 37 1,152,757 3.2 5.2     
New Hampshire         
D
ow
nloaded from
 http://ahajournals.org by on D
ecem
ber 2, 2020
 
 
New Jersey 68 3,142,733 2.2 3.8     
New Mexico     30 732,695 4.1 5.6 
New York 91 6,608,142 1.4 2     
North Carolina 13 817,694 Unreliable Unreliable 31 534,955 5.8 10 
North Dakota         
Ohio 18 770,114 Unreliable Unreliable     
Oklahoma     83 1,251,253 6.6 9.8 
Oregon 53 684,704 7.7 11.4 25 271,580 9.2 17.9 
Pennsylvania 34 1,381,709 2.5 4.8     
Rhode Island         
South Carolina         
South Dakota         
Tennessee         
Texas 92 4,257,139 2.2 3.9     
Utah 16 285,025 Unreliable Unreliable     
Vermont 35 1,919,638 1.8 3.5     
Virginia 136 2,366,488 5.7 8.1     
Washington 15 359,113 Unreliable Unreliable 50 480,902 10.4 19.3 
West Virginia         
Wisconsin 92 4,257,139 2.2 3.9 17 216,294 Unreliable Unreliable 
Wyoming         
Crude death rates and AAMR (age adjusted mortality rates) are calculated per 100,000 persons. Shaded areas suggest absence of deaths recorded. Cells are 
empty if no data were available. Crude and AAMR were reported unreliable when number of events were too low.  
 
 
 
 
 
 
 
D
ow
nloaded from
 http://ahajournals.org by on D
ecem
ber 2, 2020
 
 
Table S9. Aortic Stenosis Related Mortality Stratified by State and Race (Hispanics) in the United States, 2008-2018. 
 
 Hispanics 
State Death Population Crude rate AAMR 
Alabama     
Alaska     
Arizona 214 5,196,734 4.1 6.5 
Arkansas     
California 2,036 40,219,800 5.1 7.7 
Colorado 136 2,863,397 4.7 7.3 
Connecticut 54 1,373,343 3.9 7.3 
Delaware     
District of Columbia     
Florida 1,042 17,635,656 5.9 6.7 
Georgia 24 1,763,290 1.4 2.8 
Hawaii 36 307,198 11.7 19.9 
Idaho 12 396,133 Unreliable Unreliable 
Illinois 132 5,162,361 2.6 4.6 
Indiana 33 860,798 3.8 6.9 
Iowa 12 313,341 Unreliable Unreliable 
Kansas 27 657,763 4.1 7.5 
Kentucky     
Louisiana 21 588,202 3.6 4.4 
Maine     
Maryland 31 1,235,627 2.5 4.9 
Massachusetts 52 1,762,165 3 5.6 
Michigan 41 1,089,280 3.8 6 
Minnesota 16 489,258 Unreliable Unreliable 
Mississippi     
Missouri 11 505,369 Unreliable Unreliable 
Montana     
Nebraska 11 354,550 Unreliable Unreliable 
Nevada 66 1,900,774 3.5 6.7 
New Hampshire     
New Jersey 199 5,096,487 3.9 6.4 
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New Mexico 179 3,421,162 5.2 6.2 
New York 335 11,496,097 2.9 4 
North Carolina 23 1,547,909 1.5 3.2 
North Dakota     
Ohio 34 893,141 3.8 5.8 
Oklahoma 11 705,143 Unreliable Unreliable 
Oregon 49 975,844 5 10.8 
Pennsylvania 101 1,921,821 5.3 9.6 
Rhode Island     
South Carolina 14 506,294 Unreliable Unreliable 
South Dakota     
Tennessee     
Texas 1,194 27,699,489 4.3 6.5 
Utah 29 775,162 3.7 7.2 
Vermont     
Virginia 37 1,600,951 2.3 5 
Washington 74 1,628,776 4.5 10 
West Virginia     
Wisconsin 14 702,819 Unreliable Unreliable 
Wyoming     
Crude death rates and AAMR (age adjusted mortality rates) are calculated per 100,000 persons. Shaded areas suggest absence of deaths recorded. Cells are 
empty if no data were available. Crude and AAMR were reported unreliable when number of events were too low.  
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Figure S1. Trends in All-Cause Mortality, Cardiovascular Mortality, Cancer Related Mortality and Aortic Stenosis Related 
Mortality in the United States, 2008-2018. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Indicates that the Annual Percent Change (APC) is significantly different from zero at the alpha = 0.05. Between 2008 and 2018, following were the age-adjusted 
death rates for all-cause (2031.6 to 1876.2; AAPC, -0.7 [-1.0, -0.4]), cardiovascular (698.0 to 598.8; AAPC, -1.4 [-1.7, -1.0]), cancer (465.3 to 427.1; AAPC, -0.8 
[-1.0, -0.7]), and aortic stenosis (12.7 to 11.5; AAPC, -1.0 [-1.5, -4.1]) mortality. 
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Figure S2. Trends in Cancer Related Mortality Stratified by Sex in the United States, 2008-2018. 
*Indicates that the Annual Percent Change (APC) is significantly different from zero at the alpha = 0.05. Between 2008 and 2018,following were  the age-adjusted 
death rates for women (407.4 to 349.8; AAPC, -1.5 [-1.8, -1.3]), and men (597.7 to 491.20; AAPC, -1.9 [-2.1, -1.7]).  
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Figure S3. Trends in Cancer Related Mortality Stratified by Race in the United States, 2008-2018. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Indicates that the Annual Percent Change (APC) is significantly different from zero at the alpha = 0.05. Between 2008 and 2018, following were the age-adjusted 
death rates for Whites (485.0 to 414.0; AAPC, -1.6 [-2.1, -1.1]), Blacks (572.0 to 463.0; AAPC, -2.1 [-2.3, -1.8]), Hispanics (331.2 to 292.5; AAPC, -1.3 [-1.6, -
1.4]), Asians or Pacific Islanders (298.0 to 253.0; AAPC, -1.6 [-2.1, -1.1]), and American Indian or Alaska Native (346.0 to 268.0; AAPC, -2.3 [-3.8, -0.7]). 
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Figure S4. Trends in Aortic Stenosis Related Mortality Stratified by Age in the United States, 2008-2018. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Indicates that the Annual Percent Change (APC) is significantly different from zero at the alpha = 0.05. Between 2008 and 2018, following were the crude death 
rates for 45-54 years (0.60 to 0.60; AAPC, -0.0 [-4.7, 4.9]), 55-64 years (1.60 to 1.60; AAPC, -1.9 [3.0, 0.4]), 65-74 years (5.40 to 5.30; AAPC, -2.1 [1.9, -0.2]), 
75-84 years (28.8 to 23.3; AAPC, -2.2 [-2.9, -1.6]), and >85 years (165.2 to 153.5; AAPC, -0.7 [-1.4, 0.0]). 
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Figure S5. Trends in Aortic Stenosis Related Mortality Stratified by Urban-Rural Classification in the United States, 2008-2018. 
**Indicates that the Annual Percent Change (APC) is significantly different from zero at the alpha = 0.05. Between 2008 and 2018, following were the age-adjusted 
death rates in urban (12.9 to 11.5; AAPC, -1.0 [-1.5, 0.4]) and rural (13.3 to 14.3; AAPC, 0.6 [-0.1, 1.4]) areas. 
D
ow
nloaded from
 http://ahajournals.org by on D
ecem
ber 2, 2020
 
 
Figure S6. Trends in Aortic Stenosis Related Mortality Stratified by Place of Death in the United States, 2008-2018. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
**Indicates that the Annual Percent Change (APC) is significantly different from zero at the alpha = 0.05. Between 2008 and 2018, following were the absolute 
number of deaths for medical facility-inpatient (6158 to 6254; AAPC, 0.3 [-0.4, 1.1]), medical facility-outpatient or ER (628 to 623; AAPC, -0.3 [-1.7, 1.0]), home  
(3348 to 3536; AAPC, -3.1 [2.0, 4.1]), hospice (375 to 1136; AAPC, 12.5 [10.0, 15.0]), nursing home/long-term care (2988 to 3007; AAPC, 0.0 [-0.9, 1.0]), and 
other (583 to 682; AAPC, -0.7 [3.2, 1.2]). 
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